 CAMBRIDGE, Mass., Jan. 11, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced leadership transitions for the companys research and development organization. Effective as of January 11, 2021, Becker Hewes, M.D., currently Senior Vice President, Clinical... 